5442102026-07-135442102026-07-132026-07-135442102026-07-13in-capmkt:FinancialYear1Member5442102026-07-13in-capmkt:FinancialYear2Member5442102026-07-13in-capmkt:FinancialYear3Member5442102026-07-132026-07-13in-capmkt:FinancialYear1Member5442102026-07-132026-07-13in-capmkt:FinancialYear2Member5442102026-07-132026-07-13in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure544210Emcure Pharmaceuticals LimitedEMCURENOTLISTEDINE168P01015NewAcquisition (including agreement to acquire)false2026-07-1315:43:002026-07-13Emcure Pharmaceuticals LimitedListed Entity (self)Gennova Biopharmaceuticals Limited4920000000500000002440000000true2026-05-132026-05-13falsetrueThe Company currently owns 87.95% shareholding in Gennova, a Subsidiary and therefore, a related party. Further, a Promoter and Director of the Company is also a Director and Member of Gennova. The relatives of such Director who are Members of Gennova are also considered related parties.truePharmaceuticalsProposed acquisition/purchase of 663,865 Equity Shares, constituting 12.05% of the total issued and paid-up capital of Gennova from all its individual shareholders, will make Gennova a wholly-owned subsidiary of the Company. Emcure has entered into Share Purchase Agreement(s) with individual shareholders.NAtrueOn or before July 31, 2026Cash2318700000Cash Consideration23187000000.87950.12051Gennova Biopharmaceuticals Limited ("Gennova") was incorporated on June 19, 2001, as a public limited company under the Companies Act, 1956, with name ‘Emcure Dragon Biotech Limited’. The said name was subsequently changed to Emcure Biotech Limited on October 23, 2001. The name ‘Emcure Biotech Limited’ was further changed to ‘Gennova Biopharmaceuticals Limited’ on February 15, 2006. Gennova is involved in the business of research and development, manufacturing and marketing of biotechnology-based products.2001-06-192025-202649200000002024-202543000000002023-20244220000000India